No clinical trials have been registered for borderline ovarian serous tumor.
78 publications have been identified in PubMed for borderline ovarian serous tumor. Research spans Case Report / Case Series (31%), Review / Meta-Analysis (20%), and Diagnostic / Biomarker (19%).
Tokunaga H (2026). [PMID: 41857418](https://pubmed.ncbi.nlm.nih.gov/41857418/). *Int J Clin Oncol*. [Review / Meta-Analysis]
Badlaeva AS (2026). [PMID: 41591349](https://pubmed.ncbi.nlm.nih.gov/41591349/). *Arkh Patol*. [Epidemiology / Natural History]
Kawabata M (2026). [PMID: 41201779](https://pubmed.ncbi.nlm.nih.gov/41201779/). *Clin J Gastroenterol*. [Case Report / Case Series]
Li CL (2026). [PMID: 41957787](https://pubmed.ncbi.nlm.nih.gov/41957787/). *J Ovarian Res*. [Case Report / Case Series]
Tomita M (2026). [PMID: 41930595](https://pubmed.ncbi.nlm.nih.gov/41930595/). *Int J Gynecol Pathol*. [Case Report / Case Series]
Hattori M (2026). [PMID: 41520625](https://pubmed.ncbi.nlm.nih.gov/41520625/). *Clin Radiol*. [Diagnostic / Biomarker]
Ali BM (2026). [PMID: 41988441](https://pubmed.ncbi.nlm.nih.gov/41988441/). *Oxf Med Case Reports*. [Case Report / Case Series]
Tao L (2026). [PMID: 41869668](https://pubmed.ncbi.nlm.nih.gov/41869668/). *Front Oncol*. [Case Report / Case Series]
De Boeck A (2026). [PMID: 40970686](https://pubmed.ncbi.nlm.nih.gov/40970686/). *Histopathology*. [Diagnostic / Biomarker]
Sandrasegaran K (2026). [PMID: 40748460](https://pubmed.ncbi.nlm.nih.gov/40748460/). *Abdom Radiol (NY)*. [Review / Meta-Analysis]
